Information You Need

Transparency You Deserve

Follow our blog for news, visualization and commentaries about medication safety, intriguing data relationships and new insights.

Veracuity Blog

AI Technologies for Pharmacovigilance

Learn more about AI In pharmacovigilance by attending the virtual event “Transforming Pharmacovigilance With AI” on Feb 22nd at 10.30 AM EST Register at https://www.linkedin.com/events/7142626299835027456/ Artificial intelligence technologies have significant potential to revolutionize pharmacovigilance.  Machine learning algorithms  One of the most impactful AI applications in this field is using machine learning algorithms to detect and analyze adverse drug reactions (ADRs). These algorithms can efficiently process large volumes of data from various sources, such as electronic health records, social media, and research literature databases. By identifying patterns and correlations that human…

Transforming Pharmacovigilance With AI

Register at Linkedin Transforming Pharmacovigilance With AI is a specialized session that explores the intersection of AI and drug safety monitoring. This workshop is designed to provide a comprehensive understanding of how artificial intelligence can transform pharmacovigilance. We will discuss topics such as utilizing AI to detect adverse drug reactions, improving data analysis in drug safety, and using machine learning to predict drug interactions. Attendees will engage in an interactive learning experience and gain insights into the latest AI tools and techniques shaping pharmacovigilance’s future. The workshop aims to equip…

Will pharmacogenomic testing become a routine part of clinical care?

Veracuity Blog Will pharmacogenomic testing become a routine part of clinical care? Some adverse drug events are a predictable consequence of therapeutic, especially dosing failures. Idiosyncratic toxicities, on the other hand, are much less predictable and much more insidious. Pharmacogenomics is a powerful tool that can reveal some of these vulnerabilities before toxicity occurs or, if performed after the fact, can explain the cause of an adverse drug event that has already happened. Clinical trials cannot detect all adverse drug events due to the limited population in which the drugs…

Utilizing pharmacogenomic testing to ensure effective therapy

Veracuity Blog Will pharmacogenomic testing become a routine part of clinical care? Some medications are administered as prodrugs that need to be metabolized in the active form by the body. An example of such a drug is codeine. It undergoes biotransformation into morphine by CYP2D6. Patients who transform codeine faster who are referred to as ultrarapid metabolizers, transform codeine into morphine so fast that they can develop opioid toxicity. On the other hand, poor metabolizers would not be able to produce enough active moiety, thereby making the drug ineffective. One…

Adverse incidents of medical devices

Veracuity Blog Adverse incidents of medical devices Medical Devices Regulation 2017/745 and In Vitro Diagnostic Medical Devices Regulation 2017/746 The new European legislation places numerous new obligations on manufacturers of medical devices marketed in Europe. The current requirements for reporting adverse incidents of medical devices in Europe are detailed in the Medical Devices Directive (MDD) [1], Active Implantable Medical Devices Directive (AIMD) [2] and In-Vitro Diagnostic Devices Directive (IVDD) [3]. The current procedures are described in Guidelines on a medical devices vigilance system [4]. The manufacturer is obliged to report…